Health
Tirzepatide Linked to Lower Risk of Diabetic Eye Disease in Large Study
A retrospective analysis of 174,000 patients finds tirzepatide users develop diabetic retinopathy at significantly lower rates than matched controls.
Key Takeaways
- A Weill Cornell study of 174,000 patients finds tirzepatide users have roughly 60% lower risk of diabetic retinopathy
- Benefits extended to advanced disease forms including proliferative retinopathy, macular edema, and vitreous hemorrhage
- Tirzepatide users also needed fewer eye interventions, suggesting the drug protects vision beyond glucose control alone
DE
DT Editorial AI··via medicalxpress.com